Manual for the Extrapyramidal Symptom Rating Scale (ESRS).
نویسندگان
چکیده
The Extrapyramidal Symptom Rating Scale (ESRS) was developed to assess four types of drug-induced movement disorders (DIMD): Parkinsonism, akathisia, dystonia, and tardive dyskinesia (TD). Comprehensive ESRS definitions and basic instructions are given. Factor analysis provided six ESRS factors: 1) hypokinetic Parkinsonism; 2) orofacial dyskinesia; 3) trunk/limb dyskinesia; 4) akathisia; 5) tremor; and 6) tardive dystonia. Two pivotal studies found high inter-rater reliability correlations in both antipsychotic-induced movement disorders and idiopathic Parkinson disease. For inter-rater reliability and certification of raters, >or=80% of item ratings of the complete scale should be +/-1 point of expert ratings and >or=70% of ratings on individual items of each ESRS subscale should be +/-1 point of expert ratings. During a cross-scale comparison, AIMS and ESRS were found to have a 96% (359/374) agreement between TD-defined cases by DSM-IV TD criteria. Two recent international studies using the ESRS included over 3000 patients worldwide and showed an incidence of TD ranging from 10.2% (2000) to 12% (1998). ESRS specificity was investigated through two different approaches, path analyses and ANCOVA PANSS factors changes, which found that ESRS measurement of drug-induced EPS is valid and discriminative from psychiatric symptoms.
منابع مشابه
A Placebo-Controlled Study of Raloxifene Added to Risperidone in Men with Chronic Schizophrenia.
Selective estrogen receptor modulators (SERMs) such as raloxifene have already shown beneficial effects on negative, positive and general psychopathology symptoms in postmenopausal women with schizophrenia. The purpose of the present investigation was to assess the efficacy of raloxifene as an adjuvant agent in the treatment of men with chronic schizophrenia in an 8-week double-blind and placeb...
متن کاملMeta-analytic study of the benefits and risks of treating chronic schizophrenia with risperidone or conventional neuroleptics.
Data from six randomised, controlled, comparative studies of risperidone and conventional neuroleptics (haloperidol, zuclopenthixol and perphenazine) in the treatment of 911 patients with chronic schizophrenia were analysed to estimate the benefits and risks of treatment. Efficacy and risk of treatment were assessed by means of the Positive and Negative Syndrome Scale (PANSS) and the Extrapyram...
متن کاملاثر درمانی ریلوزول بهعنوان درمان کمکی در بهبود علائم افراد مبتلا به اسکیزوفرنی نوع مداوم
Background & Aims: This study was aimed to evaluate the efficacy of riluzole (a glutamate release inhibitor) add-on therapy in the treatment of negative symptoms of patients with chronic schizophrenia. Materials & Methods: This randomized, double-blind, and placebo-controlled study was conducted on thirty patients with continues schizophrenia (DSM-IV-TR) that were randomized considering eith...
متن کاملRisperidone monotherapy in manic inpatients: an open label, multicentre trial.
OBJECTIVE The efficacy of risperidone in acute mania has been established in several controlled clinical studies. However, this may not necessarily resemble the clinical effectiveness of this treatment, as patient populations in controlled studies are considered as being not representative. This study examined risperidone monotherapy in a sample of severe manic patients in admission ward settin...
متن کاملTardive dyskinesia associated with olanzapine in a neuroleptic-naive patient with schizophrenia.
The patient commenced olanzapine 20 mg daily, along with participation in an outpatient dual-diagnosis program. Three months later, paroxetine 20 mg daily was added for major depression, together with maintenance diazepam for withdrawal symptoms. The frequency of polysubstance use decreased gradually over the following year. At annual follow-up, parkinsonism (that is, postural rigidity, left up...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Schizophrenia research
دوره 76 2-3 شماره
صفحات -
تاریخ انتشار 2005